32C-24770-23429
4 vaccinations
1 coded response
37 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 300 / GA
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
-
2021-04-15
Dose 2 — Pfizer-BioNTech
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-21
- 2021-04-23
- 2021-04-29
- 2021-05-07
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-07-15
- 2021-10-14
-
2021-11-18
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-04-19
-
2023-01-02
Dose 4 — Pfizer-BioNTech
- 2023-01-02
-
2023-01-03
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2023-01-04
- 2023-01-05
- 2023-01-07
- 2023-01-08
- 2023-01-11
- 2023-01-16
- 2023-01-24
- 2023-01-30
-
2023-02-06
Survey response — day 35, dose 4MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-02-06
Report sent to call center — day 35, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-02-07
-
2023-02-10
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-02-14
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-15 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | Flu |
| 4 | 2023-01-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-06 | Successful 2023-02-10 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release